This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Anxiety Disorders  • Attention Deficit Hyperactivity Disorder  • Psychopharmacology  • Statistics and Research Methods  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Gen Psychiatry. 1999;56:1097-1099.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE RESULTS of the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) trial by the MTA Cooperative group^1-2 have been eagerly awaited internationally. It is a landmark in the evolution of children's mental health into an evidence-based discipline. It is particularly impressive that so detailed and intensive a treatment regimen was delivered consistently across sites for so many cases. For once, the number of subjects in a trial is enough for robust conclusions. The outcome measures do justice to the complexity of the disorder and include most of the major domains in which adverse outcomes are to be expected in untreated groups. The strong lesson is that ambitious trials are also feasible. Where there are the will and resources to test treatment practices, it can be done with sufficient rigor to command authority from statisticians, trial experts, and clinicians.

The questions asked will be highly relevant to current practice . . . [Full Text of this Article]

LONG-TERM EFFECTS


WHO SHOULD BE TREATED?

PLANNING


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
The MTA Cooperative Group
Arch Gen Psychiatry. 1999;56(12):1073-1086.
ABSTRACT | FULL TEXT  

Moderators and Mediators of Treatment Response for Children With Attention-Deficit/ Hyperactivity Disorder: The Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder
The MTA Cooperative Group
Arch Gen Psychiatry. 1999;56(12):1088-1096.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA): Part II: Supporting Details
Swanson et al.
J Atten Disord 2008;12:15-43.
ABSTRACT  

Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence
Brown et al.
Pediatrics 2005;115:e749-e757.
ABSTRACT | FULL TEXT  

Managing attention deficit/hyperactivity disorder: unmet needs and future directions
Steer
Arch. Dis. Child. 2005;90:i19-i25.
ABSTRACT | FULL TEXT  

Attention-deficit hyperactivity disorder in adults: validity unknown
Zwi and York
Adv. Psychiatr. Treat. 2004;10:248-256.
ABSTRACT | FULL TEXT  

Are psychostimulant drugs being used appropriately to treat child and adolescent disorders?
REY and SAWYER
Br. J. Psychiatry 2003;182:284-286.
FULL TEXT  

Parent Training Management for Preschool ADHD
Millichap
AAP Grand Rounds 2001;5:60-61.
FULL TEXT  

Review: pharmacological interventions are more effective than non-pharmacological for attention deficit hyperactivity disorder
Margo
Evid. Based Med. 2000;5:179-179.
FULL TEXT  

Evidence and belief in ADHD
Zwi et al.
BMJ 2000;321:975-976.
FULL TEXT  

Medication management alone or in combination with behavioural therapy was the most effective treatment for children with ADHD
Sawyer and Graetz
Evid. Based Ment. Health 2000;3:82-82.
FULL TEXT  

What the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder Did and Did Not Say About the Use of Methylphenidate for Attention Deficits
Carey
Pediatrics 2000;105:863-864.
FULL TEXT